At the news
? NEUTRALIMPACT 4/10 EFFECT filed Nov 20, 2026 at 00:15 ET
Equillium's S-3 registration statement (File No. 333-300003) became effective on November 19, 2026. The shelf registers 35,087,717 shares of common stock for resale by selling stockholders from an October 2026 private placement; the company will not receive any proceeds. This creates a potential overhang of shares that can be sold into the market at any time, but does not represent a new capital raise by the company.
- Effectiveness date: November 19, 2026
- S-3 File No. 333-300003 registers 35,087,717 shares for resale by selling stockholders
- Shares originated from a private placement that closed on October 26, 2026
- Equillium will not receive any proceeds from the resale
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access